ISIS, The Stock

[Reub]

I heard the talking heads raving about ISIS, a pharmaceutical company not the terrorist group, that has over 30 fancy biotech drugs in the pipeline. I believe that their first drug has already passed phase three trials, validating their method. ISIS, the company not the terrorist group, seems like a possible takeover candidate and it seems that these days drug companies spay a large premium when taken over as with the recent acquisition of InterMune by Roche:

http://www.foxbusiness.com/industries/2 ... 3-billion/

"Roche said on Sunday it would pay $74.00 a share through a tender offer for InterMune, representing a premium of 38 percent to the closing price on Aug. 22 and a 63 percent premium over Aug. 12 when takeover speculation around the stock began to circulate. The acquisition, which has been recommended by the boards of both companies, is the largest by Roche since 2009, when it bought out the remaining stake it did not already own in U.S. group Genentech for around $47 billion."

The talking head said that ISIS, the stock not the terrorist group, was an excellent stand alone company even without a takeover. Thoughts?

[Pointedstick]

Investing in ISIS the stock… wouldn't that be LMT, NOC, and BA?

[Reub]

That would certainly be another way to play it.

[dualstow]

Some of my favorite stocks. Don't forget Raytheon.